More than 330,000 buildings without power as ex-Tropical Cyclone Alfred brings dangerous rain and winds
EU ambassador to China urges Beijing to stop building coal-fired power plants
European markets soar as Germany moves to lift ‘debt brake’ and raise defence spending
Nigerian king faces Shell in London high court over decades of oil spills
Could Elon Musk’s newfound political influence help him finally crack India?
MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia
Britain’s drugs regulator has approved a groundbreaking treatment for two painful and debilitating lifelong blood disorders, which works by “editing” the gene that causes them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for Casgevy to be used to treat sickle cell disease and beta thalassemia.
More Stories
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Microsoft unveils chip it says could bring quantum computing within years
‘It would be seen as political’: why the Royal Society is torn over Elon Musk